National Funding
The MUR finances research mainly through the Research Programmes of Relevant National Interest (PRIN) and the Fund for Basic Research Investments (FIRB).
The DSF has obtained funding for the following projects:
PRIN
2017
- “4DInSiDe: Innovative Silicon Detectors for particle tracking in 4Dimensions”, Project leader Prof. Roberta Arcidiacono
- “Identification and validation of COmmon pathways at the CrOssrOads of neurodegeneration and Neuroprotection (COCOON)”, Project leader Prof. Pier Luigi Canonico
- “Pathogenesis of ChemotherapyInduced Peripheral Neurotoxicity (Pa-CIPN)”, Project leader Prof. Carla Distasi
- “Understanding and targeting the extracellular NADome in inflammation”, Project leader Prof. Armando Genazzani
- “Selective mGlu3 metabotropic glutamate receptor ligands as new potential therapeutic agents in experimental models of parkinsonism”, Project leader Prof. Mariagrazia Grilli
- “Novel IDO1 inhibitors at the forefront of cancer immunotherapy: from compound screening to preclinical validation in pancreatic ductal adenocarcinoma and glioblastoma multiforme”, Project leader Prof. Tracey Pirali
- “Deciphering the molecular and functional heterogeneity of myeloid cells in cancer”, Project leader Prof. Antonio Sica
- “Bioactivity-directed exploration of the phytocannabinoid chemical space”, Project leader Prof. Giovanni Battista Appendino
2015
- " Pathogenesis mechanisms in the early stages of Alzheimer's disease: identification of pharmacological targets and biomarkers", Project leader Prof. Pier Luigi Canonico
2012
- " Nanotechnologies to vary the progress of bone development in the vessel wall for the prevention and treatment of pathologies associated with arterial ectopic calcification " (project leader Prof. Michela Bosetti – DSF national coordinator)
2010-11
- "SynAD - Synaptic alterations in Alzheimer's disease: from the generation of new in vitro models to the identification of new targets " (project leader Prof. Pier Luigi Canonico)
- "Italian network for the development of multivalent nanosystems" - MULTINANOITA (project leader Prof. Grazia Lombardi)
- " The immune response mediated by NK cells against haematological neoplasms: study of the effector and regulatory functions and of innovative therapeutic approaches" (Project leader Prof. Antonio Sica)
- " Design, synthesis, and biological studies of innovative drugs towards important targets in cancer therapy " (Project leader Prof. Gian Cesare Tron)
FIRB
2011
- " Inflammation and cancer: innovative approaches based on nanotechnology " (Project leader Prof. Antonio Sica)
Other national funding:
- Istituto Zooprofilattico Sperimentale Piemonte Liguria Valle d'Aosta "Developing innovative methods for detecting emerging food allergens and evaluation of their impact on consumer health: an integrated approach" (project leader of local team Prof. Jean Daniel Coisson)
- Istituto Zooprofilattico Sperimentale Piemonte Liguria Valle d'Aosta "Taking a step forwards the preparedness for preventing crises: Improving the molecular detection of emerging pathogens in food" (project leader Prof. Marco Arlorio)
- Humanitas "The role of macrophages in primary biliary cirrhosis: novel targets for immune intervention" (project leader Prof. Chiara Porta)
Last modified 19 July 2022